You are here:
> Home Page
> Publications
> Antiviral Therapy
> Browse Articles
> Advanced Publication
Correction
Correction: Dolutegravir/abacavir/lamivudine versus current ART in virally suppressed patients (STRIIVING): a 48-week, randomized, non-inferiority, open-label, Phase IIIb study
Benoît Trottier, Jordan E Lake, Ken Logue, Cynthia Brinson, Lizette Santiago, Clare Brennan, Justin A Koteff, Brian Wynne, Judy Hopking, Catherine Granier, Michael Aboud
Corresponding author name: Justin A Koteff
Corresponding author e-mail: justin.a.koteff@viivhealthcare.com
Citation: Antiviral Therapy 2017; 22:459-460
doi: 10.3851/IMP3192
Date published online: 13 September 2017